Cancer Pathology and Prevention Program
The Cancer Pathology and Prevention Graduate Program (formerly known as Experimental Pathology) draws its faculty primarily from the Departments of Pathology and Laboratory Medicine, Epidemiology, Chemoprevention, and Health Behavior. All faculty members are well published and have an active role in education; many hold senior leadership positions at Roswell Park Cancer Institute.
A wide range of cutting-edge research is ongoing within the Graduate Program, including innovative technologies in flow cytometry (one of the top facilities in the world), cytogenetics, molecular diagnostics, molecular pathology, genetic and epigenetic control of cancer, mechanism of chemoprevention, risk biomarkers, intervention trials, cancer epidemiology and survivalship, and molecular genetics of tobacco addiction.
The Cancer Prevention research portfolio at Roswell Park is highly regarded for its depth and breadth. Matriculating students interested in doing original research towards a PhD degree have the opportunity to receive training and mentoring from experienced and renowned research scientists. The institutional philosophy at Roswell Park is built upon a collaborative foundation among laboratory scientists, prevention scientist and clinician scientists, thus providing students with excellent opportunities to be involved in translational (bench to bedside) research.
For didactic course requirements, students may choose to pursue either a cancer pathology/prevention or molecular epidemeology track, i.e. basic background in biochemistry, oncology, statistics, research techniques, immunology, cancer pathology, cancer epidemiology and chemotherapy. Generally, students spend the first two years taking the required didactic courses. After completion of the preliminary examination for admittance to the PhD candidacy, the last 2-3 years are spent full time on the thesis research. Students are strongly encouraged to attend the many seminars and education programs which are offered on campus. Of particular importance to students in the Program are the Faculty Forum (lectures given by internationally acclaimed cancer researchers from around the country), the Cancer Prevention Grand Rounds (advances in cancer prevention research presented by Roswell Park staff and invited outside speakers), and the Joint Chemotherapy/ Chemoprevention Research Rounds (chemotherapy and chemoprevention share similar experimental approaches in eliminating or suppressing cancer). Cancer prevention research is a mandated research area for all NCI-designated comprehensive cancer centers.
Roswell Park provides a dynamic environment for research training in this fast evolving field because of the richness of its basic, clinical and prevention science and the caliber of its scientists. We appreciate your interest in this program.
The application deadline for fall 2017 admission has passed. The next opportunity to apply for doctoral study at the Roswell Park Cancer Institute will be for fall 2018, and the application deadline will be January 5, 2018.
Students who wish to apply after the January 5 deadline must contact the program director before submitting an application.